A Johns Hopkins virologist has answers for you about the latest COVID variant.
Vaccines, tests, and antivirals are still effective tools against the most recent COVID surge, says Andy Pekosz, a professor in the molecular microbiology and immunology department at the Johns Hopkins University Bloomberg School of Public Health
In early November 2023, the JN.1 variant caused less than 5% of COVID-19 cases in the US. Now it is estimated to cause more than 60% of them. Virologists, including Pekosz, are paying attention.
Here, he explains what virologists are seeing, what this new variant means for case rates and treatments, and why it’s so important for more people to get the updated COVID-19 vaccine rolled out this fall:
Source: Johns Hopkins University
Author Profile
- "Center" Bias Rating
- Futurity is a nonprofit website that aggregates news articles about scientific research conducted at prominent universities in the United States, the United Kingdom, Canada, Europe, Asia, and Australia. It is hosted and edited by the University of Rochester.
Latest entries
ScienceOctober 22, 20241 AirBnB tweak could help slow rising home prices
ScienceOctober 21, 2024What’s behind the rise in ADHD diagnoses?
ScienceOctober 21, 2024Students learn better writing by hand
ScienceOctober 20, 20241 genetic mutation ups chance of having a daughter